发明名称 CYCLOPROPANECARBOXYLIC ACID COMPOUND
摘要 A compound of the formula (I): wherein each symbol is as defined in the description, a salt thereof, and a prodrug thereof of the present invention unexpectedly have a superior GPR40 receptor agonist activity and superior properties as pharmaceutical products such as stability and the like, and can be safe and useful pharmaceutical agents for the prophylaxis or treatment of GPR40 receptor-related pathology or diseases in mammals.
申请公布号 EP1916234(A1) 申请公布日期 2008.04.30
申请号 EP20060782304 申请日期 2006.07.28
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 YASUMA, T.;NEGORO, N.
分类号 C07C69/757;A61K31/192;A61K31/216;A61K31/337;A61K31/382;A61K31/426;A61P3/10;A61P43/00;C07C62/12;C07C229/46;C07D277/20;C07D277/42;C07D305/06;C07D335/02 主分类号 C07C69/757
代理机构 代理人
主权项
地址